Browse Drug Recalls

2,097 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 2,097 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 2,097 FDA drug recalls in NJ.

Clear
DateProductReasonClassFirm
Nov 7, 2024 Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-83... cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Aurobindo Pharma USA Inc
Nov 7, 2024 Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-83... cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Aurobindo Pharma USA Inc
Nov 7, 2024 Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832... cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Aurobindo Pharma USA Inc
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Ca... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dos... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dos... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dos... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 C... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Nov 1, 2024 Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosa... cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim... Class II Glenmark Pharmaceuticals Inc., USA
Oct 29, 2024 IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. ... Failed Tablet/Capsule Specifications Class III Dr. Reddy's Laboratories, Inc.
Oct 29, 2024 Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences ... Crystallization Class II VIONA PHARMACEUTICALS INC
Oct 23, 2024 Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manuf... Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets. Class II Cipla USA, Inc.
Oct 23, 2024 Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manuf... Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets. Class II Cipla USA, Inc.
Oct 22, 2024 Morphine Sulfate Extended-Release Tablets 30 mg, 100-count bottles, Rx Only,... Failed Impurities/Degradation Specification Class II Dr. Reddy's Laboratories, Inc.
Oct 22, 2024 Morphine Sulfate Extended-Release Tablets 15 mg, 100-count per bottle, Rx On... Failed Impurities/Degradation Specification Class II Dr. Reddy's Laboratories, Inc.
Oct 17, 2024 Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution, Rx Onl... Subpotent Drug Class II Keystone Industries
Oct 15, 2024 OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Lax... CGMP Deviations Class II Akron Pharma, Inc.
Oct 9, 2024 Cinacalcet Tablets, 30 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Dr. Reddy's Laboratories, Inc.
Oct 9, 2024 Cinacalcet Tablets, 60 mg, 30-count bottles, Rx Only, Dr. Reddy's Laboratorie... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Dr. Reddy's Laboratories, Inc.
Oct 9, 2024 Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories... CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit Class II Dr. Reddy's Laboratories, Inc.
Sep 30, 2024 Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only... Defective Container: Firm received complaints of broken tube at the seal. Class III Glenmark Pharmaceuticals Inc., USA
Sep 24, 2024 Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665... Defective Delivery System: The dip tube is clogged causing the spray not to work. Class II Glenmark Pharmaceuticals Inc., USA
Sep 24, 2024 Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences ... Crystallization Class II VIONA PHARMACEUTICALS INC
Sep 23, 2024 Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan in... CGMP deviations Class II Advanced Accelerator Applications USA, Inc.
Sep 17, 2024 Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distribu... Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with C... Class I Bionpharma Inc.
Sep 3, 2024 Mycophenolic Acid Delayed-Release Tablets USP, 360 mg, Rx Only, 120 Tablets p... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Aug 30, 2024 Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmac... Subpotent Drug Class II Glenmark Pharmaceuticals Inc., USA
Aug 8, 2024 Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Te... Superpotent Drug Class II Teva Pharmaceuticals USA, Inc
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 600 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% ... Class II Dr. Reddy's Laboratories, Inc.
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 400 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% ... Class II Dr. Reddy's Laboratories, Inc.
Aug 6, 2024 IBU Ibuprofen Tablets, USP, 800 mg, Rx Only, Distributor: Dr. Reddy's Laborat... Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% ... Class II Dr. Reddy's Laboratories, Inc.
Aug 1, 2024 Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: ... Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg with... Class III Amneal Pharmaceuticals, LLC
Jul 31, 2024 Indomethacin Extended-Release Capsules, USP, 75 mg, packaged in a) 60-count b... Failed Dissolution Specifications: below specification results Class II Glenmark Pharmaceuticals Inc., USA
Jul 26, 2024 Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose ... Presence of Particulate Matter: Complaint received of a glass particle in the vial. Class II Eugia US LLC
Jul 22, 2024 Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmar... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Jul 11, 2024 Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 ... Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the ... Class I Aurobindo Pharma USA Inc
Jul 9, 2024 Nitrofurantoin Capsules, USP (Macrocrystals), 100 mg, Rx Only, 100 capsules p... Failed Dissolution Specifications Class II SUN PHARMACEUTICAL INDUSTRIES INC
Jul 8, 2024 Acetaminophen Injection, 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose b... Labeling: Label Mix-up: a bag of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection was found ... Class I Hikma Pharmaceuticals USA Inc.
Jul 2, 2024 Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufa... Cross contamination with other products Class III Zydus Pharmaceuticals (USA) Inc
Jul 2, 2024 Decitabine for Injection 50mg per vial, For intravenous infusion only Cytotox... CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltere... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Jul 2, 2024 PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorba... Defective container: potential for non-sealed pouches which can lead to product leakage. Class III Novel Laboratories, Inc. d.b.a Lupin Somerset
Jul 2, 2024 Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufa... Cross contamination with other products Class III Zydus Pharmaceuticals (USA) Inc
Jul 2, 2024 Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Singl... Cross contamination with other products. Class III Zydus Pharmaceuticals (USA) Inc
Jul 2, 2024 Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a)... Cross contamination with other products. Class III Zydus Pharmaceuticals (USA) Inc
Jun 28, 2024 Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 684... Failed Dissolution Specifications: results below specifications Class II Glenmark Pharmaceuticals Inc., USA
Jun 28, 2024 Fludrocortisone Acetate Tablets, USP 0.1mg, Rx Only, 100 Tablets per bottle, ... Failed Impurities/Degradation Specifications: Product is being recalled due to API related substa... Class II Teva Pharmaceuticals USA, Inc
Jun 27, 2024 Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only,... Presence of particulate matter: glass Class II Zydus Pharmaceuticals (USA) Inc
Jun 26, 2024 Sevelamer Carbonate for Oral Suspension 0.8g packets, packaged in 90 packets ... Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on pa... Class III Dr. Reddy's Laboratories, Inc.
Jun 24, 2024 Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne ... Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testin... Class III Rising Pharma Holding, Inc.
Jun 21, 2024 Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in ... Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing ... Class II Zydus Pharmaceuticals (USA) Inc

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.